Volume 16, Number 6—June 2010
Dispatch
Causes of Infection after Earthquake, China, 2008
Table 2
Organism | No. | No. (%) specimens susceptible, by antimicrobial drug* |
||||||||
---|---|---|---|---|---|---|---|---|---|---|
AMK | AZT | CAZ | CIP | FEP | GM | IMP | SMZ | TZP | ||
A. baumannii | 74 | 16 (21.6) | 0 | 5 (6.8) | 7 (9.5) | 15 (20.1) | 0 | 26 (35.1) | 10 (13.5) | 12 (16.2) |
Escherichia coli | 36 | 36 (100) | 13 (36.1) | 13 (36.1) | 0 | 11 (30.6) | 10 (27.8) | 35 (97.2) | 11 (30.6) | 28 (77.8) |
Enteric bacilli | 30 | 15 (50.0) | 10 (33.3) | 10 (33.3) | 8 (26.7) | 13 (43.3) | 13 (43.3 | 30 (100) | 8 (26.7) | 10 (33.3 |
Klebsiella pneumoniae | 22 | 20 (90.9) | 4 (18.2) | 7 (31.8) | 0 | 7 (31.8) | 4 (18.2) | 22 (100) | 4 (18.2) | 7 (31.8) |
P. aeruginosa | 18 | 18 (100) | 4 (22.2) | 11 (61.1) | 12 (66.7) | 11 (61.1) | 15 (83.3) | 17 (94.4) | 0 | 15 (83.3) |
Total | 180 | 105 (58.3) | 31 (17.2) | 46 (25.6) | 27 (15.0) | 57 (31.7) | 42 (23.3) | 130 (72.2) | 33 (18.3) | 72 (40.0) |
*Semisusceptible results were considered resistant. AMK, amikacin; AZT, aztreonam; CAZ, ceftazidime; CIP, ciprofloxacin; FEP, cefepime; GM, gentamicin; IMP, imipenem; SMZ,sulfamethoxazole/trimethoprim; TZP, tazobactam/piperacillin; A. baumannii, Acinetobacter baumannii; P. aeruginosa, Pseudomonas aeruginosa.
Page created: February 10, 2011
Page updated: February 10, 2011
Page reviewed: February 10, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.